SEC form type
DEF 14A· Proxy statement
Definitive proxy statement disclosing matters to be voted on by shareholders, including executive compensation.
- Cadence
- Annual (pre-meeting)
- Audience
- investor
Recent filings · 23 indexed
- ACACIA RESEARCH CORPACTG0000934549-26-000016
- Aprea Therapeutics, Inc.APRE0001104659-26-052044
- Binah Capital Group, Inc. (BCG, BCGWW)0001104659-26-052871
- Light & Wonder, Inc. (LNWO, LAWIL)0001104659-26-053082
- Riot Platforms, Inc.RIOT0001104659-26-053098
- TELA Bio, Inc.TELA0001104659-26-053117
- CytomX Therapeutics, Inc.CTMX0001140361-26-018237
- Star Equity Holdings, Inc. (STRR, STRRP)0001193125-26-194281
- MAGNACHIP SEMICONDUCTOR CorpMX0001193125-26-197484
- Eledon Pharmaceuticals, Inc.ELDN0001193125-26-197732
- United Parks & Resorts Inc.PRKS0001193125-26-197833
- Syndax Pharmaceuticals IncSNDX0001193125-26-197859
- Bluejay Diagnostics, Inc.BJDX0001213900-26-050177
- TON Strategy CoTONX0001493152-26-020423
- Zoom Communications, Inc.ZM0001628280-26-028866
- TITAN INTERNATIONAL INCTWI0000899751-26-000033
- John Marshall Bancorp, Inc.JMSB0001104659-26-050977
- International Seaways, Inc.INSW0001140361-26-017661
- Heartflow, Inc.HTFL0001193125-26-189307
- Q2 Holdings, Inc.QTWO0001410384-26-000029
- C4 Therapeutics, Inc.CCCC0001628280-26-028104
- SHOULDER INNOVATIONS, INC.SI0001699350-26-000026
- Fortinet, Inc.FTNT0002077096-26-000106
Other form types
Source: SEC EDGAR. SecFilingDex is independently operated and not affiliated with the U.S. Securities and Exchange Commission. EDGAR is the authoritative source for all filings.
Sister property: HoldLens — applied-analysis surface for tracked superinvestors. Where SecFilingDex catalogs every filing, HoldLens reads the DEF 14A filings of 30 tracked managers on a −100..+100 ConvictionScore.